肺癌化疗药物敏感性的体外预测是肺癌化疗个体化的基础 ,近年来以指导临床肺癌化疗个体化用药为目的的肺癌化疗药敏试验日益受到重视。本研究采用ＳＤＩ Ｐ[1] 法对 80 1 Ｄ细胞及我科 1998年 6月～ 1999年8月肺癌手术标本进行药敏试验 ,并与四甲基偶氮唑盐 (ＭＴＴ) [2 ] 法进 The in vitro prediction of chemotherapeutic sensitivity of lung cancer is the basis of individualized chemotherapy for lung cancer. In recent years, the susceptibility testing of lung cancer chemotherapy for the purpose of individualizing chemotherapy for lung cancer chemotherapy has attracted increasing attention. In this study, SDI P[1] method was used to test the susceptibility test of 80 1 D cells and lung cancer surgical specimens from June 1998 to August 1999 in our department and with MTT [2] method. Into